Correction to: Diabetologia
The baseline insulin data given in Table 1 for the placebo group were incorrectly reported as 51 ± 10 pmol/l instead of 48 ± 10 pmol/l. This mistake also impacts on data reported in Table 4. The authors also note an error in the reported change in noradrenaline levels, from pre- to post-pioglitazone treatment (Table 4). The relevant rows from Tables 1 and 4 are reproduced here, with corrected data shown in bold. These corrections do not change the statistical significance of any comparison.
The online version of the original article can be found at https://doi.org/10.1007/s00125-017-4479-9
About this article
Cite this article
Loh, R.K.C., Formosa, M.F., Eikelis, N. et al. Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans. Diabetologia 61, 504–505 (2018). https://doi.org/10.1007/s00125-017-4514-x